Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer

Benefit of Uracil–Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer

<i>Background and Objectives</i>: Postoperative adjuvant therapy with uracil and tegafur (UFT) is often used for stage II colon cancer in Japan, but a limited number of studies have investigated the effects of UFT in these patients. <i>Materials and Methods</i>: We conducted...

Full description

Bibliographic Details
Main Authors: Po-Huang Chen, Hong-Jie Jhou, Chi-Hsiang Chung, Yi-Ying Wu, Tzu-Chuan Huang, Cho-Hao Lee, Wu-Chien Chien, Jia-Hong Chen
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Medicina
Subjects:
uracil–tegafur
colon cancer
chemotherapy
adjuvant therapy
stage IIA
Online Access:https://www.mdpi.com/1648-9144/59/1/10

Similar Items

Similar Items